3-Phenoxyaniline

3-Phenoxyaniline

SCHEMBL248578

CN(C)C1(c2cccs2)CCC(NC(=O)CCCC(=O)O)CC1.Nc1cccc(Oc2ccccc2)c1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.44
OPRL1 P41146 6/20 0.44
CCR8 P51685 2/20 0.39
NPC1 O15118 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PKM P14618 1/20 0.36
CNR2 P34972 2/20 0.36
CNR1 P21554 2/20 0.36
MAOB P27338 1/20 0.36
RAB9A P51151 1/20 0.35
LTA4H P09960 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4074080 0.85 OPRM1 (0.51) OPRM1OPRL1NPC1RAB9A
SCHEMBL4074077 0.82 OPRM1 (0.51) OPRM1OPRL1NPC1RAB9A
SCHEMBL205762 0.81 OPRM1 (0.46) OPRM1OPRL1MEN1KMT2ARAB9A
SCHEMBL206843 0.80 CHRM4 (0.41) OPRM1OPRL1MEN1KMT2ACNR2
SCHEMBL250548 0.80 OPRM1 (0.48) OPRM1OPRL1
(+)-Tranylcypromine SCHEMBL250154 0.80 OPRM1 (0.45) OPRM1OPRL1MAOB
SCHEMBL251239 0.79 OPRM1 (0.44) OPRM1OPRL1NPC1
SCHEMBL251283 0.79 OPRM1 (0.44) OPRM1OPRL1NPC1RAB9A
SCHEMBL250470 0.79 OPRM1 (0.46) OPRM1OPRL1NPC1KMT2ARAB9A
SCHEMBL249111 0.79 OPRM1 (0.46) OPRM1OPRL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed